ICOSLG and neoplasm: The levels of ICOSL transgene expression from NDV in mouse tumour cell lines directly correlated with NDV-ICOSL efficacy in these tumour models, with the best effect seen in the B16-F10 and CT26 models, and virtually no enhancement seen in the MB49 model (Fig. 4; Supplementary Fig. 5).